Tapewire

Nasdaq · USD

TSHA

Taysha Gene Therapies, Inc.

Export transactions ↓
Tapewire entity
4549
SEC CIK
0001806310
Parsed reports
120

Last 12 months

Inside the activity.

0 purchase rows · 12 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202501
Jan 202607
Feb 202601
Mar 202600
Apr 202601
May 202600
Jun 202600
Jul 202601
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 02, 2025 Filed Jun 4, 2025 20:15 UTC GrantCommon Stock 56,623 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-015571 · form4-06042025_040601.xml · nonDerivative · entry 1

Sepp-Lorenzino Laura · CIK 0001777421 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,843

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.

Read SEC document
May 30, 2025 Filed Jun 4, 2025 01:38 UTC PurchaseCommon Stock 750,000 $2.75 $2,062,500.00
Disclosure

SEC source: 0001415889-25-015480 · form4-06042025_010624.xml · nonDerivative · entry 1

Manning Paul B · CIK 0001494695 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,841,704

F1 · ownership.nature: The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB.

Read SEC document
March 11, 2025 Filed Mar 13, 2025 20:15 UTC
Alam KamranCHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 29,843 $1.69 $50,434.67
Disclosure

SEC source: 0001415889-25-007997 · form4-03132025_040301.xml · nonDerivative · entry 1

Alam Kamran · CIK 0001793412 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,242,094

F1 · kind: Represents shares withheld by the Issuer to satisfy the tax withholding obligations triggered by the vesting and settlement of restricted stock units and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 22:38 UTC
Nolan Sean P.Director · Chief Executive Officer
GrantEmployee Stock Option (right to buy) · Derivative 892,500 $0.00 Strike: $1.85 $0.00
Disclosure

SEC source: 0001415889-25-000599 · form4-01032025_100137.xml · derivative · entry 3

Nolan Sean P. · CIK 0001569926 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 892,500

Underlying: Common Stock · 892,500 shares

Expires 2035-01-02

F3 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on January 2, 2026 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 22:38 UTC
Nolan Sean P.Director · Chief Executive Officer
GrantCommon Stock 892,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-000599 · form4-01032025_100137.xml · nonDerivative · entry 1

Nolan Sean P. · CIK 0001569926 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,078,358

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSU grant was approved by the Issuer's compensation committee of the board of directors and will be effective as of the date the Issuer has an effective Registration Statement on Form S-8 registering the shares available for issuance under the 2020 Stock Incentive Plan. The RSUs will vest in four equal annual installments beginning on January 2, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 22:36 UTC
Nagendran SukumarDirector · President and Head of R&D
GrantEmployee Stock Option (right to buy) · Derivative 324,500 $0.00 Strike: $1.85 $0.00
Disclosure

SEC source: 0001415889-25-000597 · form4-01032025_100136.xml · derivative · entry 2

Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 324,500

Underlying: Common Stock · 324,500 shares

Expires 2035-01-02

F2 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on January 2, 2026 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 22:36 UTC
Nagendran SukumarDirector · President and Head of R&D
GrantCommon Stock 324,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-000597 · form4-01032025_100136.xml · nonDerivative · entry 1

Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,222,343

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSU grant was approved by the Issuer's compensation committee of the board of directors and will be effective as of the date the Issuer has an effective Registration Statement on Form S-8 registering the shares available for issuance under the 2020 Stock Incentive Plan. The RSUs will vest in four equal annual installments beginning on January 2, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 22:31 UTC
Alam KamranCHIEF FINANCIAL OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 431,000 $0.00 Strike: $1.85 $0.00
Disclosure

SEC source: 0001415889-25-000595 · form4-01032025_100118.xml · derivative · entry 2

Alam Kamran · CIK 0001793412 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 431,000

Underlying: Common Stock · 431,000 shares

Expires 2035-01-02

F2 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on January 2, 2026 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 02, 2025 Filed Jan 3, 2025 22:31 UTC
Alam KamranCHIEF FINANCIAL OFFICER
GrantCommon Stock 431,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-000595 · form4-01032025_100118.xml · nonDerivative · entry 1

Alam Kamran · CIK 0001793412 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,271,937

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSU grant was approved by the Issuer's compensation committee of the board of directors and will be effective as of the date the Issuer has an effective Registration Statement on Form S-8 registering the shares available for issuance under the 2020 Stock Incentive Plan. The RSUs will vest in four equal annual installments beginning on January 2, 2026, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
June 27, 2024 Filed Jul 1, 2024 12:00 UTC PurchaseCommon Stock 1,333,333 $2.25 $2,999,999.25
Disclosure

SEC source: 0001415889-24-018515 · form4-07012024_080703.xml · nonDerivative · entry 1

Manning Paul B · CIK 0001494695 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,333,333

Read SEC document
May 29, 2024 Filed May 31, 2024 20:18 UTC GrantStock Option (right to buy) · Derivative 98,440 $0.00 Strike: $3.17 $0.00
Disclosure

SEC source: 0001415889-24-015041 · form4-05312024_040510.xml · derivative · entry 3

Stalfort John A III · CIK 0001709418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,440

Underlying: Common Stock · 98,440 shares

Expires 2034-05-29

F3 · derivative.exercise_date: The shares vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.

Read SEC document
May 29, 2024 Filed May 31, 2024 20:18 UTC GrantCommon Stock 49,220 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-015041 · form4-05312024_040510.xml · nonDerivative · entry 1

Stalfort John A III · CIK 0001709418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,098,601

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.

Read SEC document
May 29, 2024 Filed May 31, 2024 20:18 UTC GrantStock Option (right to buy) · Derivative 98,440 $0.00 Strike: $3.17 $0.00
Disclosure

SEC source: 0001415889-24-015040 · form4-05312024_040508.xml · derivative · entry 2

Long Alison S · CIK 0001891712 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,440

Underlying: Common Stock · 98,440 shares

Expires 2034-05-29

F2 · derivative.exercise_date: The shares vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.

Read SEC document
May 29, 2024 Filed May 31, 2024 20:18 UTC GrantCommon Stock 49,220 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-015040 · form4-05312024_040508.xml · nonDerivative · entry 1

Long Alison S · CIK 0001891712 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,220

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.

Read SEC document
May 29, 2024 Filed May 31, 2024 20:18 UTC GrantStock Option (right to buy) · Derivative 98,440 $0.00 Strike: $3.17 $0.00
Disclosure

SEC source: 0001415889-24-015039 · form4-05312024_040505.xml · derivative · entry 2

Donenberg Phillip B. · CIK 0001238120 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,440

Underlying: Common Stock · 98,440 shares

Expires 2034-05-29

F2 · derivative.exercise_date: The shares vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.

Read SEC document
May 29, 2024 Filed May 31, 2024 20:18 UTC GrantCommon Stock 49,220 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-015039 · form4-05312024_040505.xml · nonDerivative · entry 1

Donenberg Phillip B. · CIK 0001238120 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,331

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.

Read SEC document
May 29, 2024 Filed May 31, 2024 20:15 UTC GrantStock Option (right to buy) · Derivative 98,440 $0.00 Strike: $3.17 $0.00
Disclosure

SEC source: 0001415889-24-015038 · form4-05312024_040501.xml · derivative · entry 2

Sepp-Lorenzino Laura · CIK 0001777421 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,440

Underlying: Common Stock · 98,440 shares

Expires 2034-05-29

F2 · derivative.exercise_date: The shares vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.

Read SEC document
May 29, 2024 Filed May 31, 2024 20:15 UTC GrantCommon Stock 49,220 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-015038 · form4-05312024_040501.xml · nonDerivative · entry 1

Sepp-Lorenzino Laura · CIK 0001777421 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,220

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of May 29, 2025 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.

Read SEC document
February 02, 2024 Filed Feb 6, 2024 21:42 UTC
Alam KamranCHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 1,288 $1.51 $1,944.88
Disclosure

SEC source: 0001415889-24-002809 · form4-02062024_090255.xml · nonDerivative · entry 1

Alam Kamran · CIK 0001793412 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 840,937

F1 · kind: Represents shares withheld by the Issuer to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:43 UTC
Alam KamranChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 590,413 $0.00 Strike: $1.71 $0.00
Disclosure

SEC source: 0001209191-24-000811 · doc4.xml · derivative · entry 2

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 590,413

Underlying: Common Stock · 590,413 shares

Expires 2034-01-02

F2 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on January 2, 2025 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:43 UTC
Alam KamranChief Financial Officer
GrantCommon Stock 590,413 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-000811 · doc4.xml · nonDerivative · entry 1

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 842,225

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest in four equal annual installments beginning on January 2, 2025, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:42 UTC
Nagendran SukumarDirector · President and Head of R&D
GrantEmployee Stock Option (right to buy) · Derivative 863,617 $0.00 Strike: $1.71 $0.00
Disclosure

SEC source: 0001209191-24-000809 · doc4.xml · derivative · entry 2

Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 863,617

Underlying: Common Stock · 863,617 shares

Expires 2034-01-02

F2 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on January 2, 2025 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:42 UTC
Nagendran SukumarDirector · President and Head of R&D
GrantCommon Stock 863,617 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-000809 · doc4.xml · nonDerivative · entry 1

Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 897,843

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest in four equal annual installments beginning on January 2, 2025, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:41 UTC
Nolan Sean P.Director · Chief Executive Officer
GrantEmployee Stock Option (right to buy) · Derivative 1,184,688 $0.00 Strike: $1.71 $0.00
Disclosure

SEC source: 0001209191-24-000807 · doc4.xml · derivative · entry 3

Nolan Sean P. · CIK 0001569926 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,184,688

Underlying: Common Stock · 1,184,688 shares

Expires 2034-01-02

F3 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on January 2, 2025 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:41 UTC
Nolan Sean P.Director · Chief Executive Officer
GrantCommon Stock 1,184,688 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-000807 · doc4.xml · nonDerivative · entry 1

Nolan Sean P. · CIK 0001569926 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,185,858

F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest in four equal annual installments beginning on January 2, 2025, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
December 14, 2023 Filed Dec 18, 2023 21:50 UTC
Alam KamranChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 187,582 $0.00 Strike: $0.70 $0.00
Disclosure

SEC source: 0001209191-23-058977 · doc4.xml · derivative · entry 1

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,582

Underlying: Common Stock · 187,582 shares

Expires 2033-12-14

F1 · derivative.exercise_date: The compensation committee of the board of directors of the Issuer certified achievement of certain performance criteria such that 70% of the option shares subject to the performance-based stock option award were earned. The shares underlying the earned potion of the option shall vest and become exercisable in three equal annual installments commencing on December 31, 2024, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
December 14, 2023 Filed Dec 18, 2023 21:47 UTC
Nagendran SukumarDirector · President and Head of R&D
GrantEmployee Stock Option (right to buy) · Derivative 334,005 $0.00 Strike: $0.70 $0.00
Disclosure

SEC source: 0001209191-23-058973 · doc4.xml · derivative · entry 1

Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 334,005

Underlying: Common Stock · 334,005 shares

Expires 2033-12-14

F1 · derivative.exercise_date: The compensation committee of the board of directors of the Issuer certified achievement of certain performance criteria such that 70% of the option shares subject to the performance-based stock option award were earned. The shares underlying the earned potion of the option shall vest and become exercisable in three equal annual installments commencing on December 31, 2024, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
December 14, 2023 Filed Dec 18, 2023 21:46 UTC
Nolan Sean P.Director · Chief Executive Officer
GrantEmployee Stock Option (right to buy) · Derivative 466,550 $0.00 Strike: $0.70 $0.00
Disclosure

SEC source: 0001209191-23-058971 · doc4.xml · derivative · entry 1

Nolan Sean P. · CIK 0001569926 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 466,550

Underlying: Common Stock · 466,550 shares

Expires 2033-12-14

F1 · derivative.exercise_date: The compensation committee of the board of directors of the Issuer certified achievement of certain performance criteria such that 70% of the option shares subject to the performance-based stock option award were earned. The shares underlying the earned potion of the option shall vest and become exercisable in three equal annual installments commencing on December 31, 2024, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
November 17, 2023 Filed Nov 20, 2023 12:35 UTC PurchaseCommon Stock 100,000 $1.63 $163,000.00
Disclosure

SEC source: 0001209191-23-055942 · doc4.xml · nonDerivative · entry 1

Manning Paul B · CIK 0001494695 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 16,566,667

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.57 to $1.68 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The shares are held directly by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Revocable Trust"). The Reporting Person is the trustee of the Revocable Trust and has sole voting and investment power with respect to the shares held by the Revocable Trust.

Read SEC document
November 01, 2023 Filed Nov 3, 2023 20:41 UTC GrantStock Option (right to buy) · Derivative 43,800 $0.00 Strike: $2.39 $0.00
Disclosure

SEC source: 0001209191-23-054339 · doc4.xml · derivative · entry 1

Long Alison S · CIK 0001891712 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,800

Underlying: Common Stock · 43,800 shares

Expires 2033-11-01

F1 · derivative.exercise_date: The shares vest in 36 equal monthly installments commencing on December 1, 2023 such that the shares will be fully vested on November 1, 2026, subject to the Reporting Person's continued service as a director through the applicable vesting date.

Read SEC document
August 24, 2023 Filed Aug 25, 2023 20:30 UTC
Alam KamranChief Financial Officer
SaleCommon Stock 33,000 $2.33 $76,890.00
Disclosure

SEC source: 0001209191-23-047323 · doc4.xml · nonDerivative · entry 1

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 258,042

F1 · kind: This sale was effected pursuant to a mandatory "sell to cover" arrangement adopted by the Reporting Person on May 26, 2023 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.185 to $2.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Read SEC document
August 16, 2023 Filed Aug 17, 2023 00:57 UTC PurchaseCommon Stock 16,466,667 $0.90 $14,820,000.30
Disclosure

SEC source: 0001209191-23-046154 · doc4.xml · nonDerivative · entry 1

Manning Paul B · CIK 0001494695 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 16,466,667

F1 · balance_after: The change in the total shares held prior to the transactions reported herein reflects a change in form of ownership and, therefore, was not required to be reported pursuant to Section 16.

F2 · ownership.nature: The shares are held directly by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Revocable Trust"). The Reporting Person is the trustee of the Revocable Trust and has sole voting and investment power with respect to the shares held by the Revocable Trust.

Read SEC document
August 16, 2023 Filed Aug 17, 2023 00:52 UTC
Nolan Sean P.Director · Chief Executive Officer
PurchaseCommon Stock 444,444 $0.90 $399,999.60
Disclosure

SEC source: 0001209191-23-046150 · doc4.xml · nonDerivative · entry 1

Nolan Sean P. · CIK 0001569926 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 1,535,545

F1 · ownership.nature: The securities are held by Nolan Capital, LLC (the "LLC"). The Reporting Person is the President of the LLC and has shared voting and investment power with respect to the shares held by the LLC.

Read SEC document
August 16, 2023 Filed Aug 17, 2023 00:53 UTC GiftCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-046152 · doc4.xml · nonDerivative · entry 3

Stalfort John A III · CIK 0001709418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,049,381

Read SEC document
August 16, 2023 Filed Aug 17, 2023 00:53 UTC PurchaseCommon Stock 388,889 $0.90 $350,000.10
Disclosure

SEC source: 0001209191-23-046152 · doc4.xml · nonDerivative · entry 2

Stalfort John A III · CIK 0001709418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 999,381

Read SEC document
August 16, 2023 Filed Aug 17, 2023 00:53 UTC PurchaseCommon Stock 388,889 $0.90 $350,000.10
Disclosure

SEC source: 0001209191-23-046152 · doc4.xml · nonDerivative · entry 1

Stalfort John A III · CIK 0001709418 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 884,290

F1 · ownership.nature: The securities are held by Gineane Holly Stalfort, as Trustee of the John A. Stalfort III 2018 Irrevocable Trust under agreement dated as of October 25, 2018.

Read SEC document
August 16, 2023 Filed Aug 17, 2023 00:51 UTC PurchaseCommon Stock 111,111 $0.90 $99,999.90
Disclosure

SEC source: 0001209191-23-046148 · doc4.xml · nonDerivative · entry 1

Donenberg Phillip B. · CIK 0001238120 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,111

Read SEC document
July 13, 2023 Filed Jul 14, 2023 20:00 UTC SaleCommon Stock 5,344 $0.70 $3,740.80
Disclosure

SEC source: 0000950170-23-032986 · ownership.xml · nonDerivative · entry 2

Session R.A. II · CIK 0001701846 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,871,747

Read SEC document
July 12, 2023 Filed Jul 14, 2023 20:00 UTC SaleCommon Stock 80,528 $0.71 $57,029.93
Disclosure

SEC source: 0000950170-23-032986 · ownership.xml · nonDerivative · entry 1

Session R.A. II · CIK 0001701846 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,877,091

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.70 - $0.73. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 23, 2023 Filed Jun 26, 2023 20:46 UTC SaleCommon Stock 18,100 $0.70 $12,735.16
Disclosure

SEC source: 0000899243-23-016491 · doc4.xml · nonDerivative · entry 2

Session R.A. II · CIK 0001701846 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,957,619

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.70 - $0.716. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 20:50 UTC GrantStock Option (right to buy) · Derivative 36,200 $0.00 Strike: $0.72 $0.00
Disclosure

SEC source: 0001209191-23-039733 · doc4.xml · derivative · entry 1

Sepp-Lorenzino Laura · CIK 0001777421 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,200

Underlying: Common Stock · 36,200 shares

Expires 2033-06-22

F1 · derivative.exercise_date: The shares vest on the earlier of June 22, 2024 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 20:50 UTC GrantStock Option (right to buy) · Derivative 36,200 $0.00 Strike: $0.72 $0.00
Disclosure

SEC source: 0001209191-23-039732 · doc4.xml · derivative · entry 1

Reape Kathleen · CIK 0001832203 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,200

Underlying: Common Stock · 36,200 shares

Expires 2033-06-22

F1 · derivative.exercise_date: The shares vest on the earlier of June 22, 2024 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 20:49 UTC GrantStock Option (right to buy) · Derivative 36,200 $0.00 Strike: $0.72 $0.00
Disclosure

SEC source: 0001209191-23-039731 · doc4.xml · derivative · entry 1

Donenberg Phillip B. · CIK 0001238120 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,200

Underlying: Common Stock · 36,200 shares

Expires 2033-06-22

F1 · derivative.exercise_date: The shares vest on the earlier of June 22, 2024 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 20:48 UTC GrantStock Option (right to buy) · Derivative 43,800 $0.00 Strike: $0.72 $0.00
Disclosure

SEC source: 0001209191-23-039730 · doc4.xml · derivative · entry 1

Stalfort John A III · CIK 0001709418 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,800

Underlying: Common Stock · 43,800 shares

Expires 2033-06-22

F1 · derivative.exercise_date: The shares vest on the earlier of June 22, 2024 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date.

Read SEC document
June 22, 2023 Filed Jun 26, 2023 20:46 UTC SaleCommon Stock 10,508 $0.70 $7,383.97
Disclosure

SEC source: 0000899243-23-016491 · doc4.xml · nonDerivative · entry 1

Session R.A. II · CIK 0001701846 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,975,719

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.70 - $0.7185. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 21, 2023 Filed Jun 22, 2023 20:00 UTC SaleCommon Stock 138,962 $0.70 $97,634.70
Disclosure

SEC source: 0000899243-23-016232 · doc4.xml · nonDerivative · entry 2

Session R.A. II · CIK 0001701846 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,986,227

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.70 - $0.719. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 20, 2023 Filed Jun 22, 2023 20:00 UTC SaleCommon Stock 295,653 $0.71 $210,209.28
Disclosure

SEC source: 0000899243-23-016232 · doc4.xml · nonDerivative · entry 1

Session R.A. II · CIK 0001701846 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,125,189

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.70 - $0.78. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 20:12 UTC
Alam KamranChief Financial Officer
GrantCommon Stock 6,230 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-033681 · doc4.xml · nonDerivative · entry 1

Alam Kamran · CIK 0001793412 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 291,042

F1 · shares: Represents a performance restricted stock unit ("PRSU") award. The PRSUs were awarded on February 2, 2023 by the Compensation Committee (the "Compensation Committee") of the Issuer's Board of Directors as annual incentive compensation for 2022 performance. On May 31, 2023, the Compensation Committee certified the achievement of a certain performance goal. The PRSUs covered by this report vested upon certification.

F2 · price: Each PRSU represented a contingent right to receive one share the Issuer's common stock.

Read SEC document
May 31, 2023 Filed Apr 10, 2025 20:15 UTC Amendment
Alam KamranCHIEF FINANCIAL OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 12,462 $0.00 Strike: $1.18 $0.00
Disclosure

SEC source: 0001415889-25-010539 · form4a-04102025_040408.xml · derivative · entry 1

Alam Kamran · CIK 0001793412 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,462

Underlying: Common Stock · 12,462 shares

Expires 2033-02-02

F1 · derivative.exercise_date: The option was awarded on February 2, 2023 by the Compensation Committee (the "Compensation Committee") of the Issuer's Board of Directors as annual incentive compensation for 2022 performance. On May 31, 2023, the Compensation Committee certified the achievement of a certain performance goal. The shares underlying the option covered by this report vested upon certification. This option was inadvertently omitted for the original Form 4.

Read SEC document
May 16, 2023 Filed May 18, 2023 20:44 UTC
Nagendran SukumarDirector · President and Head of R&D
PurchaseCommon Stock 5,000 $0.68 $3,400.00
Disclosure

SEC source: 0001209191-23-030661 · doc4.xml · nonDerivative · entry 1

Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,226

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.682 to $0.6879 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.